101Smart Ltd.

Day Case Trans-Urethral Resection of Bladder Tumour (TURBT) without a Day Surgery Unit. Making the most of the available resources.

Patrick Olaniyi, Jed Botham, Elizabeth Birch, James Pearsall, Katherine Warren, Helena Burden
Bristol Urological Institute, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom


Aim: Transurethral resection of bladder tumour (TURBT) is one of the commonest urological procedures. Day case TURBT within a day case unit has been shown to be efficient, safe and plausible. In Southmead Hospital, Bristol, there is no such day case unit. All operative procedures are performed in the main theatres, and we have a combined admission and recovery area, called Medirooms. The aim of this retrospective review of our current practice is to show that high day case rates are achievable within a non day case setting within the context of a standardised day case pathway.

Method: Retrospective data collection was performed to identify patients who underwent TURBT over a 3-month period. Basic demographics were collected, and we ascertained tumour characteristics, re-admission rates within 30 days.

Results: A total of 100 patients were included in this study. Of these, 66% were males and 34% females. TURBT was performed as a day case for 75% patients and 25% patients stayed overnight. Non-muscle invasive bladder cancer was found in 87% of the patients. Of these, 78% had muscle present and 40% received peri-operative Mitomycin in theatre. We discharged 44% patients home with a catheter after their TURBT. This was mainly due to deep resection and precaution from the operating surgeons. The rate of re-admission within 30-days was 9%, of which 6% were due to urological reasons and 3% were due to non urological reasons.

Conclusions: This study shows that day case TURBT is possible without a dedicated day case unit.